‘The craving is just not there’: How Ozempic is affecting snacking culture

  • 📰 GlobalCalgary
  • ⏱ Reading Time:
  • 32 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 16%
  • Publisher: 61%

Education Education Headlines News

Education Education Latest News,Education Education Headlines

A survey published Tuesday by Dalhousie University, Halifax, estimates that between 900,000 and 1.4 million Canadians use GLP-1 receptor agonists.

WATCH: Global BC medical contributor Dr. Birinder Narang explains how the diabetes drug Ozempic works for weight loss and discusses the potential side effects. – Mar 15, 2023may be stirring up the food industry, with a recent report revealing that Canadians on certain drugs are tightening their belts on restaurant outings, snack indulgences and drinking alcohol.. These are a group of drugs used to treat Type 2 diabetes and are often used to combat obesity.

As more Canadians start using Ozempic and other related weight loss medications, researchers at Dalhousie University sought to investigate the potential implications of this shift on future food industry trends. When asked about the reason for using a GLP-1 drug, 57 per cent of respondents attributed it to Type 2 diabetes management, 27 per cent cited weight loss as their primary reason and 11 per cent stated it was for both purposes.“We believe that anywhere between 250,000 to 400,000 people are using a GLP-1 drug to lose weight in Canada. So that’s about the size of Halifax,” Charlebois told Global News.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 50. in EDUCATİON

Education Education Latest News, Education Education Headlines